These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23530114)

  • 21. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.
    Coumans FAW; Doggen CJM; Attard G; de Bono JS; Terstappen LWMM
    Ann Oncol; 2010 Sep; 21(9):1851-1857. PubMed ID: 20147742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
    Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
    Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ
    BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
    Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
    PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression.
    Kolostova K; Pinterova D; Hoffman RM; Bobek V
    Anticancer Res; 2011 May; 31(5):1535-9. PubMed ID: 21617207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
    Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
    PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
    Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
    Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
    Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
    Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.